Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond D Blind

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Biochemical and Biophysical Research Communications|April 3, 2012
Ligand structural motifs can decouple glucocorticoid receptor transcriptional activation from target promoter occupancyRaymond D Blind, Inés Pineda-Torra, Yong Xu, et al.
ACS Chemical Biology|April 19, 2023
New High-Throughput Screen Discovers Novel Ligands of Full-Length Nuclear Receptor LRH-1M Merced Malabanan, Pratima Chapagain, Zeinab Haratipour, et al.
Methods in Enzymology|March 27, 2026
Expression and purification of Steroidogenic Factor-1 (NR5A1) nuclear receptor ligand binding domain complexed with the signaling phosphoinositide lipid PI(3,4,5)P<sub>3</sub>Alexis N Campbell, Alexander J Cutright, Jessica Martin, et al.
Structure (London, England : 1993)|May 21, 2020
Integrated Structural Modeling of Full-Length LRH-1 Reveals Inter-domain Interactions Contribute to Receptor Structure and FunctionCorey D Seacrist, Georg Kuenze, Reece M Hoffmann, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
Design, synthesis and cellular characterization of a new class of IPMK kinase inhibitorsYubai Zhou, Pratima Chapagain, Desmarini Desmarini, et al.
Cancer Research|June 25, 2009
Stimulating the GPR30 estrogen receptor with a novel tamoxifen analogue activates SF-1 and promotes endometrial cell proliferationBenjamin C Lin, Miyuki Suzawa, Raymond D Blind, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
IPMK regulates HDAC3 activity and histone H4 acetylation in human cellsGregory A Sowd, Elizabeth A Stivison, Pratima Chapagain, et al.
Journal of Structural Biology|September 30, 2015
Structure of Liver Receptor Homolog-1 (NR5A2) with PIP3 hormone bound in the ligand binding pocketElena P Sablin, Raymond D Blind, Rubatharshini Uthayaruban, et al.
Molecular Endocrinology (Baltimore, Md.)|November 8, 2008
Structure of SF-1 bound by different phospholipids: evidence for regulatory ligandsElena P Sablin, Raymond D Blind, Irina N Krylova, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 8, 2014
The signaling phospholipid PIP3 creates a new interaction surface on the nuclear receptor SF-1Raymond D Blind, Elena P Sablin, Kristopher M Kuchenbecker, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Biochemical and Biophysical Research Communications|April 3, 2012
Ligand structural motifs can decouple glucocorticoid receptor transcriptional activation from target promoter occupancyRaymond D Blind, Inés Pineda-Torra, Yong Xu, et al.
ACS Chemical Biology|April 19, 2023
New High-Throughput Screen Discovers Novel Ligands of Full-Length Nuclear Receptor LRH-1M Merced Malabanan, Pratima Chapagain, Zeinab Haratipour, et al.
Methods in Enzymology|March 27, 2026
Expression and purification of Steroidogenic Factor-1 (NR5A1) nuclear receptor ligand binding domain complexed with the signaling phosphoinositide lipid PI(3,4,5)P<sub>3</sub>Alexis N Campbell, Alexander J Cutright, Jessica Martin, et al.
Structure (London, England : 1993)|May 21, 2020
Integrated Structural Modeling of Full-Length LRH-1 Reveals Inter-domain Interactions Contribute to Receptor Structure and FunctionCorey D Seacrist, Georg Kuenze, Reece M Hoffmann, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
Design, synthesis and cellular characterization of a new class of IPMK kinase inhibitorsYubai Zhou, Pratima Chapagain, Desmarini Desmarini, et al.
Cancer Research|June 25, 2009
Stimulating the GPR30 estrogen receptor with a novel tamoxifen analogue activates SF-1 and promotes endometrial cell proliferationBenjamin C Lin, Miyuki Suzawa, Raymond D Blind, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
IPMK regulates HDAC3 activity and histone H4 acetylation in human cellsGregory A Sowd, Elizabeth A Stivison, Pratima Chapagain, et al.
Journal of Structural Biology|September 30, 2015
Structure of Liver Receptor Homolog-1 (NR5A2) with PIP3 hormone bound in the ligand binding pocketElena P Sablin, Raymond D Blind, Rubatharshini Uthayaruban, et al.
Molecular Endocrinology (Baltimore, Md.)|November 8, 2008
Structure of SF-1 bound by different phospholipids: evidence for regulatory ligandsElena P Sablin, Raymond D Blind, Irina N Krylova, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 8, 2014
The signaling phospholipid PIP3 creates a new interaction surface on the nuclear receptor SF-1Raymond D Blind, Elena P Sablin, Kristopher M Kuchenbecker, et al.
Pageof 4